Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamara Ziglioli

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Rheumatology|August 3, 2011
Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritisMirko Scarsi, Tamara Ziglioli, Paolo Airo'
The Journal of Rheumatology|March 17, 2010
Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical responseMirko Scarsi, Tamara Ziglioli, Paolo Airò
Clinical Reviews in Allergy & Immunology|November 26, 2009
Complement activation and pregnancy failureAngela Tincani, Ilaria Cavazzana, Tamara Ziglioli, et al.
Rheumatology (Oxford, England)|August 28, 2012
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?Rossella Reggia, Tamara Ziglioli, Laura Andreoli, et al.
The Journal of Rheumatology|April 3, 2012
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictorsFlorenzo Iannone, Elisa Gremese, Fabiola Atzeni, et al.
Autoimmunity Reviews|July 17, 2012
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registryFabiola Atzeni, Piercarlo Sarzi-Puttini, Costantino Botsios, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Rheumatology|August 3, 2011
Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritisMirko Scarsi, Tamara Ziglioli, Paolo Airo'
The Journal of Rheumatology|March 17, 2010
Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical responseMirko Scarsi, Tamara Ziglioli, Paolo Airò
Clinical Reviews in Allergy & Immunology|November 26, 2009
Complement activation and pregnancy failureAngela Tincani, Ilaria Cavazzana, Tamara Ziglioli, et al.
Rheumatology (Oxford, England)|August 28, 2012
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?Rossella Reggia, Tamara Ziglioli, Laura Andreoli, et al.
The Journal of Rheumatology|April 3, 2012
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictorsFlorenzo Iannone, Elisa Gremese, Fabiola Atzeni, et al.
Autoimmunity Reviews|July 17, 2012
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registryFabiola Atzeni, Piercarlo Sarzi-Puttini, Costantino Botsios, et al.
Pageof 1